AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2012
Aug 29, 2012
30016_dirs_2012-08-29_bafe3432-6ed8-47f4-9305-c8c75e408f4e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-08-27
Reporting Person: DEADY CONAN R (Corp VP, General Counsel & Sec)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-27 | Common Stock | M | 3448 | $56.95 | Acquired | 17192 | Direct |
| 2012-08-27 | Common Stock | S | 9194 | $94.81 | Disposed | 7998 | Direct |
| 2012-08-29 | Common Stock | S | 2000 | $95.31 | Disposed | 5998 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-27 | Non-Qualified Stock Option (right to buy) | $56.95 | M | 3448 | Acquired | 2015-02-13 | Common Stock (3448) | Direct |
Footnotes
F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.80
to $94.97, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F2: Grant of options to buy shares of common stock becomes exercisable as to 3,449 shares on 02/14/2009 and 02/14/2010, 3,448 shares on 02/14/2011 and 02/14/2012, and the remaining 1,693 shares on 02/14/2013.